The number of questions about this one is going off the charts, so I’ll look into it for you — even though it’s related to not one but two bubblicious sectors that are designed for the manipulation of investors, so I might get a little grumpy. Bear with me. Here’s a little tantalizer from the […]
Articles
- Most Relevant
- Most Recent
“If you complete and return the 2-page form sampled above, your broker could pay you $2,100 in less than 2 weeks. What’s even more incredible is that soon after you could receive an additional check for about $1,200.” That’s the latest “free money” tease from the folks at Stansberry & Associates — leading us into […]
This article originally appeared on June 3, it has not been updated. “If you complete and return the 2-page form sampled above, your broker could pay you $2,100 in less than 2 weeks. What’s even more incredible is that soon after you could receive an additional check for about $1,200.” That’s the latest “free money” […]
I haven’t written much about the Palm Beach Letter, but Tom Dyson and Michael Masterson/Mark Ford have been given free reign to pitch their newsletter to most of the Agora and Stansberry mailing lists, it appears, so we sure see a lot of their ads. And lots of folks have been asking about this one, […]
The Foolies are really ramping up their advertising again, it seems — I haven’t had this many questions about a teaser in quite a while. The ad now is for their flagship Stock Advisor newsletter, and it teases “The Motley Fool’s #1 Stock”. Here’s how they get us started: “While America is captivated by the […]
ss
That provocative headline is there to get your attention, of course — plenty of folks disagree with Warren Buffett on one thing or another, but few believe him to be “mad.” No, what Hilary Kramer is trying to do is to draw your attention to the fact that Buffett finally bought a tech stock, IBM […]
We see pitches about the “end of money” all the time — across the spectrum from the goofy spiel for “loyalty points” being the next Bitcoin, to actually trading in Bitcoin, to the more popular “end of America” pitch about the dollar dying and the need to have old silver coins and gold in your […]
Untold millions of readers (OK, not millions — in the tradition of the folks we write about every day, we’ll use quotes that enable us to make stuff up … so, untold “millions”) have been asking us about the “long-lost” treasure maps that are chatted up in Sean Broderick’s latest teaser for his Red-Hot Global […]
Time for another look at a growth stock being teased by Cabot — this time, it’s a pitch for Cabot Growth Investor ($99/yr) from Mike Cintolo, and he’s following in the footsteps of a great many folks in predicting “The Next Amazon.” And who could blame you for being interested in that, right? Amazon has […]
Today’s teaser ad comes in from Nathan Slaughter, who’s trying to entice us to subscribe to his Scarcity & Real Wealth newsletter, a new offering from the StreetAuthority folks that’s focused, as you can probably guess, on investing in mining, energy and commodities. And though the ad has been running for about two weeks as […]
Sometimes a tease comes in as a heavy promo push, sometimes it’s a slightly more subtle pile of hints in a free article that gently suggests that you subscribe to their premium service … today’s item for sleuthification is the latter. Louis Basenese, who is pitching for the White Cap Report, wrote a free article […]
Dr. David Eifrig is one of the Stansberry writer/editors, and for a couple of years now he has put out the Retirement Millionaire newsletter that seems to be largely focused on ways to get special perqs and discounts as a retireee … as well as a bit of financial commentary and ideas, I’m told (I […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. He has agreed to our trading restrictions, chooses his own topics, and his words and opinions are his own. All of his past articles and most recent comments are on his Stock Gumshoe page.] “I live in the light of the bright summer […]
We don’t have one big story that’s catching my eye today, so I’ll do some catching up and musing for you. We’re heading into a slow week, so it’s likely there won’t be many new articles during Thanksgiving week — other than our annual “Turkey of the Year” reveal, of course. I often get asked […]
Today I’ll try to keep my blather a little more limited than usual… I have one update on a stock that I bought recently, and a couple updates on our watchlist this week (that list always lingers down there at the bottom of the Real Money Portfolio, in case you’ve missed it). The update is […]
The response was pretty overwhelmingly positive when I started sending out those “Trade Note” emails this week… so I’ll stick with it for a while, at least, and see how this goes. What does that mean? Same day buy/sell notes about my Real Money Portfolio will be sent to the Irregulars going forward, in hopes […]
Proven Profits Review: In this review of Matt Baker’s Proven Profit’s software we will reveal our test results that prove it’s a scam! Our Official Proven Profits Software Review About The Proven Profits Software: Product Name: Proven Profits Niche: Binary Option Trading Software Price: Free Product Creator: Matt Baker Product Summary: Proven Profits is a […]
“While most folks earn tiny 2%-6% dividends on Blue Chips (like Pepsi, Johnson & Johnson, and AT&T) savvy Americans are secretly “boosting” those small yields to dizzying heights – earning incredible 30%-50% on the exact same shares. Originally available only to executives at America’s richest Blue Chip firms, this income secret is now available to […]
These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Marcelo Lima has a retailer to share today — he argues that retail is not as dead as we think it migth be — notes examples of South Koreans […]
Valhalla Vaults – The first Subscription based long term cold storage Bitcoin Investment toolDear Travis, I represent Valhalla Vaults and would like to share this new investment tool with you and your community : http://www.valhalla-vaults.com/ If you have any questions then please respond and I will answer as soon as possible. Best Regards Adam Bennett – Co Founder Valhalla Vaults About Valhalla Vaults Located in The Hague, NL., […]
Travis- I so much appreciate and enjoy you and the exceptional irregular-shoes here. I have several thoughts/ideas I’d like share: Have you ever considered: 1. A ”Beyond the decimal” (sub penny) and/or pre- and after-market discussion area(s)? 2. An investor tools link area i.e. finvis, barchart, bloomberg, otcmarkets, zacks etc, not only for links but […]
[ed note: Michael Jorrin, who I like to call “Doc Gumshoe”, is a longtime medical writer (not a doctor) who shares his thoughts with us from time to time, generally on non-financial topics in health and medicine (as today, though he mentions a couple publicly traded companies). His words and opinions are his own.] Let’s […]
Braden Copeland used to work for Porter Stansberry, co-editing his Stansberry’s Investment Advisory and working on Inside Strategist (since shuttered) that picked stocks based on insider buying. Earlier this year, he moved down the street to a different Agora-affiliated office to work for Bill Bonner’s son, Will, at Bonner & Partners and launch a newsletter […]
I always get a lot of food for thought when I go to the Value Investing Congress, so I’ve got a teaser solution and some updates for your Friday File enjoyment but I thought I’d start with some musing about the Congress ideas that percolated to the top for me on the train ride home… […]
These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Most investors know Muddy Waters and Carson Block, who build his short-selling investment portfolio by pulling away the veil that covered up the many China frauds several years ago, […]
These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Marcelo Lima has a retailer to share today — he argues that retail is not as dead as we think it migth be — notes examples of South Koreans […]
These are my notes and instant reactions from a presentation at the Value Investing Congress, the notes below might contain errors, paraphrases, incorrect quotes, or misinterpretations. Sahm Adrangi is a relatively new guy to the value investing world, Kerrisdale Capital is about five years old and (unlike many) they share their research — particularly on […]
Crocker is a comanager at the Metropolitan Capital hedge fund. His big question is figuring out Groupe Fnac — European retailer and ticketing business (the “Ticketmaster of France). It’s priced as if disaster is around the corner, and it has a huge cash balance. Stores are mainly in France, Spain and Portugal, a few others. […]
I think I saw this ad a few months ago and didn’t write about it for one reason or another, but it just started a heavy rotation again — so let’s have a gander. David Gardner is a growth stock dynamo — he and his brother Tom founded the Motley Fool as an AOL chat […]
[Ed. Note: Dr. KSS writes about medical topics and biotech stocks for the Irregulars. He has agreed to our trading restrictions, and his thoughts and words are his own. Enjoy!] Here we are, solidly in the postmodern 21st century, “so late in the goddam day,” as one of novelist Martin Amis’s characters says, and what […]
This week there’s been quite a bit of news in stocks that I follow fairly closely or own or have featured in the past as “Idea of the Month” candidates for the irregulars, so I do have a bit of a teaser campaign to talk to you about (that’s the Casey bit), but I’m going […]
[ed. note: Michael Jorrin, who I like to call “Doc Gumshoe” (he’s a longtime medical writer, not a doctor) writes about health and medicine topics for us from time to time. His words and thoughts are his own.] Let me begin with a disclaimer: I am not skinny, but neither am I fat. This chapter […]
[ed note: We got a lot of questions about this pitch after we solved a different DeHaemer teaser yesterday, so we’ve brought it up for all to see again. The stock spiked up in the Spring, a few months after this article first ran back in January, but has come back down to a bit […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own. Enjoy!] In the Saturday morning Looney Tunes many of us saw as children, one trope always stuck with me: that of the grand piano falling from way up high and crashing, splintering itself. There’s a […]
This month I want to take a look at a stock I’ve mentioned in the past, but have not yet personally bought. But first, I thought I’d call your attention to another wave of negativity that could be hitting Seadrill (SDRL) shares — Elliot Gue, who was one of the first newsletter folks to call […]
[Ed. Note: Dr. KSS writes about medicine and biotech stocks for the Irregulars. His words and opinions are his own.] In A History of New York, Washington Irving opens chapter VIII thus: ”In which the author and reader…fall into a very grave and instructive discourse.” This may prove to be a more unleavened column than […]
Paul Goodwin edits the Cabot China and Emerging Markets report, which is really the only surviving China-focused newsletter I can think of from a big publisher (most publishers had such a letter during the China bull run in the mid-late 2000s, but many of them disappeared in recent years as China got to be as […]
[Ed. Note: Myron Martin is a longtime reader who writes for the Irregulars a couple times a month about junior miners and other stocks that strike his fancy. Below is his latest contribution. As always, he’s agreed to our trading restrictions and his words and opinions are his own.] Happy Anniversary Gumshoers! Hard to believe, […]
Online advertising is a rapidly growing industry, dominated by Facebook and Google (particularly in this country) but still changing rapidly and amenable to new ideas and new technologies. Better ideas and better algorithms allow businesses in this segment to grow rapidly or get acquired at lofty prices by the established players, so it’s always interesting […]